With SCHOTT Pharma AG & Co. KGaA, a new German stock will be included in the global market from 28 September 2023. According to its own information, SCHOTT Pharma, headquartered in Mainz, is a global leader in the pharmaceutical industry and develops solutions for drug containment and delivery systems, such as pharmaceutical syringes, cartridges, vials, and ampoules. The stock market debut of the pharmaceutical subsidiary of the glass company SCHOTT AG will take place at tomorrow’s IPO in Frankfurt. Immediately after the first pricing at Deutsche Börse, the new stock will also be continuously tradable on the international market segment of the Vienna Stock Exchange.
The global market offers domestic investors a broad selection of around 800 international shares from 25 countries. Austrian investors can trade on their national stock exchange at domestic fees and during local trading hours. As market maker Lang & Schwarz ensures additional liquidity and attractive prices.